SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 115.68 |
Enterprise Value ($M) | 96.55 |
Book Value ($M) | 12.20 |
Book Value / Share | 0.69 |
Price / Book | 9.48 |
NCAV ($M) | 12.20 |
NCAV / Share | 0.69 |
Price / NCAV | 9.48 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.82 |
Return on Assets (ROA) | -1.37 |
Return on Equity (ROE) | -1.81 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 2.75 |
Current Ratio | 2.75 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 19.18 |
Assets | 19.18 |
Liabilities | 6.98 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -22.90 |
Net Income | -22.26 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -15.95 |
Cash from Investing | 0.00 |
Cash from Financing | 15.09 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Mosseri Marlio Charles | 15.00 | 9.03 | |
13G | Pontifax Management 4 G.p. (2015) Ltd. | 5.30 | ||
13G/A | Shemesh Shay | 8.60 | 23.72 | |
13G/A | Poradosu Enrique | 8.70 | 23.43 | |
13G/A | Peters Thomas Phineas | 5.20 | -4.13 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
315603 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
4,051 | 6,973 | 58.10 | |
9,233 | 21,164 | 43.63 | |
9,096 | 13,978 | 65.07 | |
4,422 | 14,387 | 30.74 | |
(click for more detail) |
Similar Companies | |
---|---|
NRSN – NeuroSense Therapeutics Ltd. | NRXP – NRx Pharmaceuticals, Inc. |
NTBL – Notable Labs, Ltd. | OCEA – Ocean Biomedical, Inc. |
OCGN – Ocugen, Inc. |
Financial data and stock pages provided by
Fintel.io